CELC

NASDAQ HEALTHCARE

Celcuity LLC

$68.07

$2.27 (+3.45%)

Live quote

52w: $53.54 – $151.02

Loading chart…

P/E Ratio—

P/B Ratio—

EV/EBITDA—

Debt/Equity—

ROE—

ROIC—

Revenue Growth—

Gross Margin—

Celcuity Inc., a clinical-stage biotechnology company, discovers cancer subtypes and therapeutic options for cancer patients in the United States. The company is headquartered in Minneapolis, Minnesota.

Own CELC? Track it here.

Create a free account to add CELC to a portfolio and watch your P/L update in real time.

Custom screens, valuation models and backtesting are coming to Pro.

Create a free account